|
Apr 24
|
Novartis and Medicines for Malaria Venture announce positive efficacy and safety data for a novel treatment for babies <5 kg with malaria
|
|
Apr 23
|
Why Novartis Stock Topped the Market on Tuesday
|
|
Apr 23
|
FDA Approves Novartis' Lutathera As First Therapy For Pediatric Patients With Gastroenteropancreatic Neuroendocrine Tumors
|
|
Apr 23
|
How Novartis Rode Two Blockbuster Drugs To Its Beat And Raise, And Three-Day Sprint
|
|
Apr 23
|
Novartis radioligand therapy Lutathera® FDA approved as first medicine specifically for pediatric patients with gastroenteropancreatic neuroendocrine tumors
|
|
Apr 23
|
Top Midday Stories: Shares of GE, Novartis, Danaher and Philip Morris Up Post-Earnings; Pepsi Stock Down Post-Earnings; Apple iPhone China Sales Drop 19%; Trump Poised for Windfall From Media Company Stock
|
|
Apr 23
|
Novartis Stock Jumps After Beating Expectations, Raising Guidance
|
|
Apr 23
|
Novartis Ag (NVS) Q1 2024 Earnings Call Transcript
|
|
Apr 23
|
Novartis raises full-year guidance on Q1 beat, drug sales
|
|
Apr 23
|
Incyte (INCY) to Report Q1 Earnings: What's in the Cards?
|
|
Apr 23
|
Compared to Estimates, Novartis (NVS) Q1 Earnings: A Look at Key Metrics
|
|
Apr 23
|
Novartis (NVS) Q1 Earnings, Sales Beat, Guidance Raised
|
|
Apr 23
|
The Zacks Analyst Blog Highlights Novartis, American Express, ConocoPhillips, Netflix and Schlumberger
|
|
Apr 23
|
Former Bristol Myers CEO tapped as Novartis’ next board chair
|
|
Apr 23
|
Novartis raises forecasts as top drug sales beat Wall Street estimates
|
|
Apr 23
|
Trending tickers: Tesla, ABF, Novartis, Taylor Wimpey, JD Sports
|
|
Apr 23
|
UPDATE 1-Healthcare, tech stocks boost STOXX 600 to one-week high
|
|
Apr 23
|
Novartis Raises Guidance on Profit, Sales Growth
|
|
Apr 23
|
Techs boost STOXX to one-week high; euro zone data on tap
|
|
Apr 23
|
UPDATE 4-Novartis raises guidance after beating Q1 expectations
|